All the doctors at New Hope Fertility Center and patients hope that everyone would have a good result from their treatments, and we are all looking forward to be able to help many couples and women achieve their dream of being a parent.
Preimplantation genetic diagnosis (PGD) can be done during IVF treatment to identify embryos with genetic defects. The intention is to identify which embryos are healthiest and to avoid the use of embryos that will result in pregnancy loss. Additionally, the PGD process allows parents to avoid passing down a genetic disease.
In continuing to post about some of my unique and interesting cases, this article will address my standard practice of care in the treatment of patients who are suffering from polycystic ovarian syndrome (PCOS) after undergoing in vitro fertilization (IVF).
Among the areas of focus that we have at New Hope Fertility Center is Poly Cystic Ovary Syndrome or PCOS. Often colleagues and patients alike want to know: how does NHFC manage individuals with PCOS during their IVF process? Let’s look at a case to see how New Hope Managed to successfully treat a difficult and common situation.
Preimplantation genetic diagnosis (PGD) can be done during IVF treatment to identify embryos with genetic defects. The intention is to identify which embryos are healthiest and to avoid the use of embryos that will result in pregnancy loss. Additionally, the PGD process allows parents to avoid passing down a genetic disease. As with any medical procedure, PGD has pros and cons. Ultimately, there is no one answer about the use of PGD. It is a highly personal decision that each couple must consider.
During in vitro fertilization (IVF) treatment, doctors have a number of tools at their disposal to increase success rates. One of these tools is preimplantation genetic diagnosis, commonly referred to as PGD. PGD is a method of testing embryos during IVF treatment to determine if an embryo has a genetic disease or chromosomal defect. Both of these issues can result in pregnancy loss, so transferring healthy embryos is ideal to increase the likelihood of a live birth and healthy child.
Although genetic testing of embryos has been done for years, the growing popularity of the process has raised ethical questions. Preimplantation genetic diagnosis (PGD) provides a method for identifying embryos with genetic diseases. Ethicists question if people should be able to decide which embryos survive and are implanted. Additionally, ethicists question which diseases should be eligible for PGD. Understanding both sides of the argument may help you make the right decision for your family.
For couples at a high risk for genetic disease, the decision to have children is not a simple one. Couples must weigh their desire for children with the likelihood of a chromosomal defect. Thankfully, preimplantation genetic diagnosis, commonly referred to as PGD, allows genetic diseases to be identified in embryos as a part of in vitro fertilization. The embryos are tested prior to transfer and implantation to ensure healthy embryos are transferred.